Cite
HARVARD Citation
Rodriguez, C. et al. (2022). Clinical Trial Development in TP53-Mutated Locally Advanced and Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma. Journal of the National Cancer Institute. pp. 1619-1627. [Online].